Antagonism of the serotonin (5-HT)-2 receptor and insulin sensitivity: Implications for atypical antipsychotics

Psychosomatic Medicine

Volumn 67, Issue 5, 2005, Pages 748-751

  Gilles, Maria ^a   Wilke, Annette ^a   Kopf, Daniel ^a   Nonell, Annemarie ^a   Lehnert, Hendrik ^b   Deuschle, Michael ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

5 HT2 antagonism; Euglycemic hyperinsulinemic clamp technique; Impaired insulin sensitivity

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; ESPARMA; FLUPENTIXOL; HALOPERIDOL; KETANSERIN; OLANZAPINE; PAROXETINE; PHENOXYBENZAMINE; PLACEBO; QUETIAPINE; RISPERIDONE; SEROTONIN 2 RECEPTOR; SERTRALINE; ZIPRASIDONE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; SKELETAL MUSCLE; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; INSULIN; INSULIN RESISTANCE; KETANSERIN; MALE; MUSCLE, SKELETAL; PLACEBOS; RECEPTORS, SEROTONIN, 5-HT2; RISK FACTORS; SEROTONIN ANTAGONISTS;

EID: 25844496908     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000174994.91245.34     Document Type: Article

References (27)

1. Dixon L, Weiden P, Delahanty J, Goldberg R, Postrado L, Lucksted A, Lehman A. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 2000;26:903-12.
2. Newcomer JW, Haupt DW, Fucetola R, Melson AK, Schweiger JA, Cooper BP, Selke G. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 2002;59:337-45.
3. Gianfresco FD, Grogg AL, Mahmoud RA, Wang RH, Nasrallah HA. Differential effects of risperidone, olanzapin, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database. J Clin Psychiatry 2002;63:920-30.
4. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT Jr, Friedman A, Kleinberg D, Yevich SJ, Davis B, Shon S. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004;161:1334-49.
5. a. FDA Patient Safety News; Show 28, June 2004. Warning about hyperglycemia and atypical antipsychotic drugs. URL address http://www. accessdata.fda.gov/scripts/cdrh/cfdocs/psn/printer.cfm?id=229
6. Gerlach J. The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment. J Clin Psychiatry 1999; 60(suppl 23):20-4.
7. Meyer PS, Bond GR, Tunis SL, McCoy ML. Comparison between the effects of atypical and traditional antipsychotics on work status for clients in a psychiatric rehabilitation program. J Clin Psychiatry 2002;63:108-16.
8. Dwyer DS, Bradley RJ, Kablinger AS, Freeman AM 3rd. Glucose metabolism in relation to schizophrenia and antipsychotic drug treatment. Ann Clin Psychiatry 2001;13:103-13.
9. Muldoon MF, Kackey RH, Williams KV, Korytkowski MT, Flory JD, Manuck SB. Low central nervous system serotonergic responsivity is associated with the metabolic syndrome and physical inactivity. J Clin Endocrinol Metab 2004;89:266-71.
10. Hajduch E, Dombrowki L, Darakhshan F, Rencurel F, Marette A, Hundal HS. Biochemical localisation of the 5-HT2A (serotonin) receptor in rat skeletal muscle. Biochem Biophys Res Commun 1999;257:369-72.
11. Hajduch E, Rencurel F, Balendran A, Batty IH, Downes CP, Hun HS. Serotonin (5-hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle. J Biol Chem 1999;274:13563-8.
12. Rattigan S, Dora KA, Colquhoun EQ, Clark MG. Serotonin-mediated acute insulin resistance in the perfused rat hindlimb but not in incubated muscle: a role for the vascular system. Life Sci 1993;53:1545-55.
13. Rattigan S, Clark MG, Barett EJ. Acute vasoconstriction-induced insulin resistance in rat muscle in vivo. Diabetes 1999;48:564-69.
14. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classifications of Diabetes Mellitus. Diabetes Care 1997; 20:1183-97.
15. Anderson PE, Lithell H. Metabolic effects of doxazosin and enalapril in hypertriglyceridemic, hypertensive men: relationship to changes in skeletal muscle blood flow. Am J Hypertens 1996;9(4 pt 1):323-33.
16. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237: E214-23.
17. Leucht S, Pitschel-Walz G, Engel RR, Kissling W. Amisulpride, an unusual "atypical" antipsychotic: a metaanalysis of randomized controlled trials. Am J Psychiatry 2002;159:180-90.
18. Henderson DC. Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence? CNS Drugs 2002;16:77-89.
19. Nasrallah H. A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 2003;28(suppl 1):83-96.
20. Breum L, Bjerre U, Bak JF, Jacobson S, Astrup A. Long-term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: influence on muscle glycogen synthase and insulin receptor kinase activity. Metabolism 1995; 44:1570-6.
21. Goodnick PJ, Kumar A, Henry JH, Buki VM, Goldberg RB. Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacol Bull 1997;33:261-4.
22. Paile-Hyvarinen M, Wahlbeck K, Eriksson JG. Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial. BMC Fam Pract 2003;4:7.
23. Fogari R, Zoppi A, Derosa G, Lusardi P, Mugellini A, Lazzari P. Ketanserin effects on insulin sensitivity in nonobese, nondiabetic hypertensive patients: an evaluation by the euglycemic-hyperinsulinemic clamp technique. Int J Clin Pharmacol Ther 1995;33:453-6.
24. 2 receptors. Life Sci 1981;28: 1015-22.
25. Ribeiro RT, Lautt WW, Legare DJ, Macedo MP. Insulin resistance induced by sucrose feeding in rats is due to an impairment of the hepatic parasympathetic nerves. Diabetologia 2005; May; 48: 976-83; Epub 2005 Apr 14.
26. Huupponen R, Lehtonen A, Vahatalo M. Effect of doxazosin on insulin sensitivity in hypertensive non-insulin dependent diabetic patients. Eur J Clin Pharmacol 1992;43:365-8.
27. Ambrosch A, Muhlen I, Kopf D, Augustin W, Dierkes J, Konig W, Luley C, Lehnert H. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects. Diabetes Care 1998; 21:2077-84.